Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS withdrawal · 2025-01-23

Clinical Trial Update: Mobile App for Smoking Cessation and Mental Health [Phase 2]

View source ↗

Summary

A Phase 2 trial evaluating a mobile app for smoking cessation and mental health has been suspended, with University of Oklahoma as sponsor.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: University of Oklahoma | Conditions: Smoking Cessation, Mental Illness | Phase 2 | Status: SUSPENDED